Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury

• Sponsor: RenJi Hospital (Other)
• Overall Status: Unknown status
• CT.gov ID: NCT02347930
• Collaborator: China-Japan Friendship Hospital (Other), National Cheng-Kung University Hospital (Other)
• Enrollment: 300
• Location: 1
• Duration (Months): 35
• Patients Per Site Per Month: 8.6

Study Details

Study Description

Brief Summary

Establish an integrated evaluation system of ultrasound technology for the prognosis of acute kidney injury, and in order to achieve non-invasive, reliable early diagnosis "gold standard". Set up collabration with the expert in National Cheng Kung University Medical Center of Taiwan who did a lot of excellent work in basic research of prevention the progression of acut kidney injury. Study the experience about prevention progression of kidney disease in clinical and basic field. Establish cooperation with the professional in Hong Kong University of Science and Technology. To set up the system of natural products research and assess the Astragalus medicinal value.

Condition or Disease	Intervention/Treatment	Phase
Acute Kidney Injury	Other: kidney ultrasound

Study Design

• Study Type: Observational
• Anticipated Enrollment: 300 participants
• Observational Model: Other
• Time Perspective: Prospective
• Official Title: Establish and Apply the Evaluation System of Ultrasonic Integrated Technology for Prevention and Treatment of Acute Kidney Injury
• Study Start Date: Apr 1, 2014
• Anticipated Primary Completion Date: Mar 1, 2017
• Anticipated Study Completion Date: Mar 1, 2017

Arms and Interventions

Arm	Intervention/Treatment
Confirmed acute kidney injury Confirmed acute kidney injury	Other: kidney ultrasound; kidney ultrasound

Outcome Measures

Primary Outcome Measures

1. compare the results of kidney ultrasound with biomarkers of acute kidney injury [up to 24 months]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 80 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Subjects must satisfy the following criteria to be enrolled in the study:

1. Clinical diagnosis of acute or chronic kidney injury

2. Male or female, aged 18-80 years old

3. signed informed consent

4. Patients can breathe in, breathe out and hold their breathe with ease, communication without difficulty.

Exclusion Criteria:

• Potential subjects who meet any of the following criteria will be excluded from participating in the study:

1. Refuse to sign informed consent

2. allergy to micro bubble hexafluoride drug

3. Patients with cardiopulmonary insufficiency, pleural effusion, pulmonary infections

4. Patients with asthma, chronic bronchitis

5. Patients with pregnancy

6. Patients can't cooperate or have a difficulty in breathing in, breathing out or holding their breathe

7. Patients beening diagnosed with End-stage kidney disease.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Department of nephrology , Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine	Shanghai	Shanghai	China	200127

Sponsors and Collaborators

• RenJi Hospital
• China-Japan Friendship Hospital
• National Cheng-Kung University Hospital

Investigators

• Principal Investigator: shan mou, Dr., Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: RenJi Hospital
• ClinicalTrials.gov Identifier: NCT02347930
• Other Study ID Numbers: 2014DFT30090
• First Posted: Jan 28, 2015
• Last Update Posted: Mar 30, 2017
• Last Verified: Oct 1, 2015

• Keywords provided by RenJi Hospital: acute kidney injury; ultrasound technology
• Additional relevant MeSH terms: Acute Kidney Injury; Wounds and Injuries

Study Results

No Results Posted as of Mar 30, 2017